Collaboration is a key element of the Clinical Genomics Program mission to accelerate scientific discovery related to the understanding, diagnosis, and treatment of genetically based immune disorders. The program cultivates both public and private collaborations with institutions and investigators from around the world in an effort to foster scientific discovery. Listed below are some of the institutions, companies, and partnerships developed among Clinical Genomics Program researchers:
- Merck
- Regeneron
- Novartis
- Broad
- Cambridge
- Yale
- University of Michigan
- Qatar Women and Children's Hospital
- Kansas City Children's Mercy Hospital
- Cincinnati Children's Hospital
- Boston's Children's Hospital
- University of Pennsylvania
- Tubitak (Turkey)
- University Hospitals in Ankara, Hacettepe, Marmara, and Istanbul
- National Institute of Immunohaematology, Mumbai
- Christian Medical College at Vellore, Tamil Nadu
- University of British Columbia
- American University of Beirut Medical Center